Literature DB >> 25579438

Gene Targeting Through Homologous Recombination in Monkey Embryonic Stem Cells Using CRISPR/Cas9 System.

Shengyun Zhu1, Zhili Rong, Xiaofeng Lu, Yang Xu, Xuemei Fu.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25579438      PMCID: PMC4425224          DOI: 10.1089/scd.2014.0507

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


× No keyword cloud information.
  7 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 2.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

3.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

4.  Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system.

Authors:  Jean Livet; Tamily A Weissman; Hyuno Kang; Ryan W Draft; Ju Lu; Robyn A Bennis; Joshua R Sanes; Jeff W Lichtman
Journal:  Nature       Date:  2007-11-01       Impact factor: 49.962

5.  An effective approach to prevent immune rejection of human ESC-derived allografts.

Authors:  Zhili Rong; Meiyan Wang; Zheng Hu; Martin Stradner; Shengyun Zhu; Huijuan Kong; Huanfa Yi; Ananda Goldrath; Yong-Guang Yang; Yang Xu; Xuemei Fu
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

6.  Homologous recombination in human embryonic stem cells using CRISPR/Cas9 nickase and a long DNA donor template.

Authors:  Zhili Rong; Shengyun Zhu; Yang Xu; Xuemei Fu
Journal:  Protein Cell       Date:  2014-04       Impact factor: 14.870

7.  Genetic approach to track neural cell fate decisions using human embryonic stem cells.

Authors:  Xuemei Fu; Zhili Rong; Shengyun Zhu; Xiaocheng Wang; Yang Xu; Blue B Lake
Journal:  Protein Cell       Date:  2014-01-29       Impact factor: 14.870

  7 in total
  4 in total

1.  Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.

Authors:  So Gun Hong; Ravi Chandra Yada; Kyujoo Choi; Arnaud Carpentier; T Jake Liang; Randall K Merling; Colin L Sweeney; Harry L Malech; Moonjung Jung; Marcus A F Corat; Aisha A AlJanahi; Yongshun Lin; Huimin Liu; Ilker Tunc; Xujing Wang; Maryknoll Palisoc; Stefania Pittaluga; Manfred Boehm; Thomas Winkler; Jizhong Zou; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 2.  Application of CRISPR/Cas9 System in Establishing Large Animal Models.

Authors:  Yingqi Lin; Jun Li; Caijuan Li; Zhuchi Tu; Shihua Li; Xiao-Jiang Li; Sen Yan
Journal:  Front Cell Dev Biol       Date:  2022-05-17

3.  HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies.

Authors:  Shuai Liu; Qiankun Wang; Xiao Yu; Yilin Li; Yandan Guo; Zhepeng Liu; Fuyun Sun; Wei Hou; Chunmei Li; Li Wu; Deyin Guo; Shuliang Chen
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

4.  Robust and efficient knock-in in embryonic stem cells and early-stage embryos of the common marmoset using the CRISPR-Cas9 system.

Authors:  Sho Yoshimatsu; Junko Okahara; Takefumi Sone; Yuta Takeda; Mari Nakamura; Erika Sasaki; Noriyuki Kishi; Seiji Shiozawa; Hideyuki Okano
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.